What is the correct action if a CSP is observed to have an unusual color or precipitate?

When a Compounded Sterile Preparation (CSP) displays an unusual color or precipitate, the correct course of action is to dispose of the preparation immediately. This is crucial because such changes can indicate that the CSP has degraded, is contaminated, or may not be safe for administration. Using or retaining a preparation that shows signs of alteration poses significant risks to patient safety, as it can lead to adverse reactions or ineffective treatment.

Other potential actions, such as testing for potency, examining under a microscope, or using it only in emergencies, are inadequate responses in this situation. Testing the preparation could potentially expose healthcare personnel to hazardous materials if contamination is present. Microscopic examination may not reveal the underlying issue that affects safety, and using the preparation in emergencies does not align with best practices for patient safety. Proper protocols for handling CSPs emphasize the importance of adhering to established guidelines that prioritize the health and well-being of patients. Disposing of potentially unsafe preparations is a fundamental principle in sterile compounding to ensure that only safe, high-quality medications are administered.